>
Switch to:

National Research Equity-to-Asset

: 0.53 (As of Sep. 2021)
View and export this data going back to 1997. Start your Free Trial

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. National Research's Total Stockholders Equity for the quarter that ended in Sep. 2021 was $83.1 Mil. National Research's Total Assets for the quarter that ended in Sep. 2021 was $156.2 Mil. Therefore, National Research's Equity to Asset Ratio for the quarter that ended in Sep. 2021 was 0.53.

The historical rank and industry rank for National Research's Equity-to-Asset or its related term are showing as below:

NAS:NRC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.18   Med: 0.64   Max: 0.81
Current: 0.53

0.18
0.81

During the past 13 years, the highest Equity to Asset Ratio of National Research was 0.81. The lowest was 0.18. And the median was 0.64.

NAS:NRC's Equity-to-Asset is ranked lower than
59% of the 247 Companies
in the Medical Diagnostics & Research industry.

( Industry Median: 0.61 vs. NAS:NRC: 0.53 )

National Research Equity-to-Asset Historical Data

The historical data trend for National Research's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

National Research Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Equity-to-Asset
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.69 0.71 0.18 0.30 0.48

National Research Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Equity-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.48 0.50 0.50 0.53

Competitive Comparison

For the Diagnostics & Research subindustry, National Research's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

National Research Equity-to-Asset Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, National Research's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where National Research's Equity-to-Asset falls into.



National Research Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

National Research's Equity to Asset Ratio for the fiscal year that ended in Dec. 2020 is calculated as

Equity to Asset (A: Dec. 2020 )=Total Stockholders Equity/Total Assets
=64.315/133.423
=0.48

National Research's Equity to Asset Ratio for the quarter that ended in Sep. 2021 is calculated as

Equity to Asset (Q: Sep. 2021 )=Total Stockholders Equity/Total Assets
=83.128/156.186
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


National Research  (NAS:NRC) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


National Research Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of National Research's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


National Research Business Description

National Research logo
Industry
Traded in Other Exchanges
Address
1245 Q Street, Lincoln, NE, USA, 68508
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. It operates in the US and Canada, of which key revenue is derived from the US.
Executives
Jackson Steven D. officer: President C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508
Martin Joann M director 6221 ANDREW COURT LINCOLN NE 68512
Nunnelly John N director P.O. BOX 2175 AMHERST MA 01004
Karas Kevin R officer: SVP Finance, CFO, Treas & Secy C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508
Berwick Donald M director C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508
Mowry Barbara director P.O. BOX 103115 DENVER CO 80250
Amandla Mk Trust 10 percent owner C/O THE BRYN MAWR TRUST COMPANY OF DELAW 20 MONTCHANIN RD, SUITE 100 GREENVILLE DE 19807
Hays Michael D. director, officer: CEO C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508
K/i/e Trust Under Agreement 10/24/18 10 percent owner C/O BESSEMER TRUST COMPANY OF DELAWARE 1007 N. ORANGE ST., SUITE 1450 WILMINGTON DE 19801
Endacott Kent E. 10 percent owner C/O WOODS & AITKEN LLP 301 SOUTH 13TH STREET, SUITE 500 LINCOLN NE 68508
Beans Patrick E director, officer: CFO and Secretary AMANDLA LLC 709 PIER 2 LINCOLN NE 68528
Warden Gail L director 250 WASHINGTON RD GROSSE POINTE MI 48230
Henricks Susan L officer: President and COO C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508
Schorr Paul C Iii director PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: SCHORR PAUL C III a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;}
Peetz Jeffery T 10 percent owner WOODS & AITKEN LLP 301 SOUTH 13TH STREET, SUITE 500 LINCOLN NE 68508
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)